(Q37387695)

English

The urokinase plasminogen activator system: a target for anti-cancer therapy.

scientific article published on February 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

19200050

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19200050%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

The urokinase plasminogen activator system: a target for anti-cancer therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

19200050

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19200050%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

1

1 reference

stated in

Europe PubMed Central

PubMed ID

19200050

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19200050%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

Enke Baldini

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

19200050

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19200050%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

Salvatore Sorrenti

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

19200050

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19200050%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

author name string

Massimino D'Armiento

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed ID

19200050

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19200050%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

publication date

1 February 2009

1 reference

stated in

Europe PubMed Central

PubMed ID

19200050

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19200050%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

published in

Current Cancer Drug Targets

1 reference

stated in

Europe PubMed Central

PubMed ID

19200050

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19200050%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

volume

9

1 reference

stated in

Europe PubMed Central

PubMed ID

19200050

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19200050%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

page(s)

32-71

1 reference

stated in

Europe PubMed Central

PubMed ID

19200050

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19200050%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

issue

1

1 reference

stated in

Europe PubMed Central

PubMed ID

19200050

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19200050%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

cites work

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M503111200

Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-06-2892

Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M705867200

Small interfering RNA directed reversal of urokinase plasminogen activator demethylation inhibits prostate tumor growth and metastasis

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-07-0751

RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/IJC.22962

Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-06-4277

(Q37387695)

The urokinase plasminogen activator system: a target for anti-cancer therapy.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)